Almaden Genomics adds pre-built workflows to g.nome, facilitating and speeding single-cell RNA-Seq analysis
Almaden Genomics has added pre-built workflows for single-cell RNA-seq analysis to its g.nome platform, enabling…
Browsing: Press Release
NVIGEN pioneers breakthrough in high-resolution tissue RNA sequencing with magnetic nanoparticle capture
NVIGEN, a leading provider of modern nanoparticle solutions to empower revolutionary personalized healthcare, announces its…
Advancements in genome sequencing propel global RNA sequencing market growth to 2030
The global RNA sequencing market is witnessing rapid growth, driven by the increasing adoption of…
Fluent BioSciences awarded NIH SBIR grant to revolutionize single cell analysis
Fluent BioSciences, a cutting edge life sciences company leading the charge in revolutionizing single cell analysis…
Why are researchers going beyond mutations to study cancer?
Cancer is an incredibly complex system, and researchers in Toronto have found that mutations alone…
Celsius Therapeutics Announces Initiation of Dosing in Phase 1 Clinical Trial of CEL383, an Anti-TREM1 Antibody for the Treatment of Inflammatory Bowel Disease
Celsius Therapeutics, a biotechnology company pioneering new precision medicines for patients with inflammatory disease by…
Single-nuclei RNA sequencing detects gene splicing defect known as “cryptic exons” in ALS
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating neurodegenerative diseases with mean survival…
GeneCentric Therapeutics announces publication of new results showing clinical benefit of RNA-based Antifolate Predictive Response Signature (AF-PRS) to guide lung cancer treatment selection
The Piedmont Study, a Real-World Data Analysis in Patients Treated with Platinum Doublet Chemotherapy and/or…
Hummingbird Diagnostics announces publication of miLung small RNA-based blood test data for early detection of lung cancer
Hummingbird Diagnostics GmbH, a leader in reading blood-based small RNAs for early disease detection and…
Tempus launches standalone RNA sequencing test, xR
Tempus, a leader in artificial intelligence and precision medicine, introduces its standalone RNA next-generation sequencing assay, Tempus…